Berenberg upgraded Sanofi to Buy from Hold with a price target of EUR 115, up from EUR 107. In context of the Inflation Reduction Act and associated price cuts for large, mature brands, the firm favors companies with strong pipeline momentum and attractive research and development returns. The analyst says Sanofi is seeing some “bright spots” in its pipeline.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SNY:
- Biotech Alert: Searches spiking for these stocks today
- Amazon Pharmacy to automate discounts for insulin, Reuters reports
- Sanofi was second bidder for Reata, Bloomberg reports
- Sanofi says CDC panel unanimously recommends use of Beyfortus for infants
- AstraZeneca and Sanofi RSV drug wins support of CDC panel, Bloomberg says